These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6264868)

  • 41. Correlation between HBeAg/anti-HBe and other hepatitis B virus (HBV) markers in healthy carriers.
    Musca A; Cordova C; Barnaba V; Zaccari C
    Quad Sclavo Diagn; 1981 Sep; 17(3):363-9. PubMed ID: 7343989
    [No Abstract]   [Full Text] [Related]  

  • 42. [Incidence of HAV and HBc antibodies in patients with chronic hepatitis].
    Tanno H; Fay O; Roncoroni M; Galimberti B; Palazzi J
    Acta Gastroenterol Latinoam; 1980; 10(2):105-11. PubMed ID: 7211130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Serologic markers of hepatitis].
    Guimarães RX; Vilela MP
    AMB Rev Assoc Med Bras; 1981 Oct; 27(10):281-4. PubMed ID: 6979764
    [No Abstract]   [Full Text] [Related]  

  • 44. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
    Chen DS; Sung JL; Lai MY
    Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence and significance of hepatitis B and A virus serologic markers in Greek cirrhotic patients.
    Theodoropoulos G; Hadzis G
    Gastroenterol Jpn; 1985 Oct; 20(5):436-40. PubMed ID: 4076727
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Co-existence of HBeAg and anti-HBe in a subject with prolonged hepatitis B].
    Cirelli A; Catania S
    Clin Ter; 1981 Jul; 98(2):215-7. PubMed ID: 7261568
    [No Abstract]   [Full Text] [Related]  

  • 47. Human interferon alfa therapy and hepatitis B virus markers in the serum of patients with chronic course of illness.
    Stancek D; Fuchsberger N; Borecký L; Kotuliaková M; Hrúzik J; Sylvanová E; Sudová J
    Acta Virol; 1988 Mar; 32(2):148-52. PubMed ID: 2899961
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Leprosy and hepatitis B].
    Chiron JP; Denis F; Yvonnet B; Coursaget P; Diop Mar I; Languillon J
    Acta Leprol; 1985; 3(2):169-99. PubMed ID: 3907255
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hepatitis B virus antigens and antibodies in acute infection].
    Ketiladze ES; Zhilina NN; Vorozhbieva TE; Goldberg EZ; Farber NA
    Vopr Virusol; 1980; (2):232-6. PubMed ID: 7385794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Frequency of the detection of hepatitis A and B viral markers in blood donors in the Moldavian SSR].
    Tsybuliak SN
    Vopr Virusol; 1988; 33(1):89-92. PubMed ID: 2835875
    [No Abstract]   [Full Text] [Related]  

  • 51. Hepatitis A and B markers and presumable non-A, non-B hepatitis in a psychiatric institution.
    Gmelin K; von Ehrlich-Treuenstätt B; Doerr HW; Klee F; Rappold E; Middelhoff HD; Gebhardt P; Kommerell B
    Zentralbl Bakteriol Mikrobiol Hyg B; 1982 Apr; 176(1):15-27. PubMed ID: 6287759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Incidence of HBeAg in hemodialysis patients: preliminary data (author's transl)].
    Toti M; Alegente G; Almi P; Rubino M; Marini M; Facchini C
    Ann Sclavo; 1980; 22(3):455-8. PubMed ID: 7247498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Radioimmunological investigation (HBsAg, HBsAb, HBcAb) and its significance for reducing the risk of hepatitis B transmission through blood (author's transl)].
    Novák J; Kselíková M
    Cas Lek Cesk; 1979 Oct; 118(40-41):1235-8. PubMed ID: 393397
    [No Abstract]   [Full Text] [Related]  

  • 54. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 55. [Detection of HBeAg among HBsAg-positive patients with various hepatic diseases and epidemiologic significance of the findings].
    Xu HW
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Aug; 4(4):226-9. PubMed ID: 6640636
    [No Abstract]   [Full Text] [Related]  

  • 56. Viral hepatitis A and B in hemodialysed patients.
    Gmelin K; von Ehrlich B; Kommerell B; Ritz E; Bommer J
    Klin Wochenschr; 1980 Apr; 58(7):365-70. PubMed ID: 6248680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lymphocytotoxins in leprosy and in asymptomatic hepatitis B virus infection.
    Serjeantson S; Dry P
    Clin Exp Immunol; 1980 Feb; 39(2):289-96. PubMed ID: 7389201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serological pattern of hepatitis B virus markers (HBsAg, anti-HBs, IgM anti-HBc and HBV specific DNA polymerase) in leprosy patients.
    Moudgil KD; Irshad M; Gandhi BM; Mishra R
    Indian J Lepr; 1989 Jan; 61(1):54-60. PubMed ID: 2649622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [HBsAg and HBsAb in haematology and blood transfusion service (author's transl)].
    Lipsic T; Geso L; Malícková D; Hrubisko M
    Cas Lek Cesk; 1980 Sep; 119(36-37):968-70. PubMed ID: 7438168
    [No Abstract]   [Full Text] [Related]  

  • 60. [Prevalence of surface antigens (HBsAg), surface antibody (HBsAb) and anticore antibody (HBcAb) in hospital personnel and patients with and without hepatic pathology].
    Ardito D; Bianco T; Demundo T; Loiodice L
    Minerva Med; 1980 Oct; 71(39):2815-20. PubMed ID: 7432690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.